ClinicalTrials.govcontrolled
Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
ClinicalTrials.gov study NCT03194867. IPD Sharing: YES. Countries: 10. Publications: 0.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4